12 research outputs found

    Synthesis and Characterization of a New Peptide Prodrug of Glucosamine with Enhanced Gut Permeability

    Get PDF
    The aim of this study was to synthesize a peptide prodrug of glucosamine (GlcN) with increased gut permeability through the gut peptide transporter 1 (PepT1). Glycine-Valine ester derivative of GlcN (GVG) was synthesised using solid phase synthesis followed by characterization and evaluation of its physicochemical and intestinal stability. In addition, GVG was evaluated for its ability to be biotransformed to GlcN in the liver homogenate. In vitro absorption of the new prodrug through everted rat gut was also assessed. GVG demonstrated significant and meaningful increased gut permeability as compared with GlcN. It showed favorable stability in the gut and a quick cleavage to GlcN after exposure to the liver homogenate. In conclusion, a novel prodrug of glucosamine with superior gut permeability compared to GlcN was developed and successfully tested in vitro

    Synthetic scheme for solid-phase synthesis of GVG.

    No full text
    <p>Synthetic scheme for solid-phase synthesis of GVG.</p

    Characterization of the Gly-Val-COO-GlcN (GVG) ester derivative using 1H NMR spectroscopy.

    No full text
    <p>1H NMR [CD3OD, 400 MHz]: [D2O, 400 MHz]: δ 5.40 (d, 1H, J = 2.9 Hz, H1α), 4.95 (d, 1H, J = 7.5 Hz, H1β), 4.30–4.65 (m, 3H, H5, H6a and H7), 4.06–4.14 (m, 1H, H6b), 3.90 (s, 2H, H10), 3.66–3.85 (m, 1H, H4), 3.45–3.65(m, 1H, H3). 3.00 and 3.30 (m, 1H, H2), 2.20–2.40 (m, 1H, H8), 0.99 (d, 6H, J = 8.6 Hz, H9).</p

    Mass spectra of the Gly-Val-COO-GlcN (GVG) conjugate before (A) and after (B) purification using <i>Diaion HP</i>-<i>20</i> resin (MW = 335.357).

    No full text
    <p>Mass spectra of the Gly-Val-COO-GlcN (GVG) conjugate before (A) and after (B) purification using <i>Diaion HP</i>-<i>20</i> resin (MW = 335.357).</p

    Synthetic scheme for solid-phase synthesis of GVG.

    No full text
    <p>Synthetic scheme for solid-phase synthesis of GVG.</p

    Characterization of the Gly-Val-COO-GlcN (GVG) ester derivative using 13C NMR spectroscopy.

    No full text
    <p>13C NMR [D2O, 150 MHz]: δ 172.8 (C12), 167.2 (C7), 92.7 and 89.1 (C1α and C1β), 73.5, 71.7 and 69.5 (C3, C4 and C5), 63.8 (C6), 58.5 (C8), 56.5 (C2), 40.2 (C13), 30.0 (C9), 18.1 and 17.1 (C10 and C11).</p

    Chemical structure of GVG.

    No full text
    <p>Chemical structure of GVG.</p

    Cumulative amount of GlcN (μg) inside the jejunum sacks (serosal site) (<i>n</i> = 6) at different time points, after incubation with 1.5 μM of GlcN or GVG.

    No full text
    <p>Data are shown as mean (±SD). Different superscript letters denote significant differences between means in a column (<i>P</i> < 0.05).</p><p>Cumulative amount of GlcN (μg) inside the jejunum sacks (serosal site) (<i>n</i> = 6) at different time points, after incubation with 1.5 μM of GlcN or GVG.</p
    corecore